Atrion (ATRI) Revenue & Revenue Breakdown
Atrion Revenue Highlights
Latest Revenue (Q)
$48.77M
Main Segment (Y)
Fluid Delivery
Main Geography (Y)
United State
Atrion Revenue by Period
Atrion Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $183.51M | 11.21% |
| 2021-12-31 | $165.01M | 11.80% |
| 2020-12-31 | $147.59M | -4.82% |
| 2019-12-31 | $155.07M | 1.72% |
| 2018-12-31 | $152.45M | 3.99% |
| 2017-12-31 | $146.59M | 2.17% |
| 2016-12-31 | $143.49M | -1.54% |
| 2015-12-31 | $145.73M | 3.53% |
| 2014-12-31 | $140.76M | 6.64% |
| 2013-12-31 | $131.99M | 10.86% |
| 2012-12-31 | $119.06M | 1.15% |
| 2011-12-31 | $117.70M | 8.41% |
| 2010-12-31 | $108.57M | 7.88% |
| 2009-12-31 | $100.64M | 4.95% |
| 2008-12-31 | $95.89M | 8.31% |
| 2007-12-31 | $88.54M | 9.28% |
| 2006-12-31 | $81.02M | 12.39% |
| 2005-12-31 | $72.09M | 9.09% |
| 2004-12-31 | $66.08M | 5.22% |
| 2003-12-31 | $62.80M | 5.49% |
| 2002-12-31 | $59.53M | 3.35% |
| 2001-12-31 | $57.60M | 11.97% |
| 2000-12-31 | $51.45M | 3.10% |
| 1999-12-31 | $49.90M | 14.98% |
| 1998-12-31 | $43.40M | 43.23% |
| 1997-12-31 | $30.30M | -77.72% |
| 1996-12-31 | $136.00M | 69.15% |
| 1995-12-31 | $80.40M | 14.37% |
| 1994-12-31 | $70.30M | -40.92% |
| 1993-12-31 | $119.00M | - |
Atrion generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Atrion Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $48.77M | 3.04% |
| 2024-03-31 | $47.33M | 8.60% |
| 2023-12-31 | $43.58M | 3.99% |
| 2023-09-30 | $41.91M | -4.40% |
| 2023-06-30 | $43.84M | 9.61% |
| 2023-03-31 | $39.99M | -6.68% |
| 2022-12-31 | $42.85M | -3.98% |
| 2022-09-30 | $44.63M | -8.70% |
| 2022-06-30 | $48.88M | 3.70% |
| 2022-03-31 | $47.14M | 16.99% |
| 2021-12-31 | $40.29M | -5.98% |
| 2021-09-30 | $42.85M | 0.38% |
| 2021-06-30 | $42.69M | 9.00% |
| 2021-03-31 | $39.17M | 21.48% |
| 2020-12-31 | $32.24M | -4.56% |
| 2020-09-30 | $33.78M | -11.02% |
| 2020-06-30 | $37.97M | -12.91% |
| 2020-03-31 | $43.59M | 26.48% |
| 2019-12-31 | $34.47M | -11.36% |
| 2019-09-30 | $38.88M | -3.04% |
| 2019-06-30 | $40.10M | -3.63% |
| 2019-03-31 | $41.61M | 19.15% |
| 2018-12-31 | $34.93M | -11.07% |
| 2018-09-30 | $39.27M | 1.10% |
| 2018-06-30 | $38.85M | -1.41% |
| 2018-03-31 | $39.40M | 15.80% |
| 2017-12-31 | $34.02M | -10.23% |
| 2017-09-30 | $37.90M | 4.81% |
| 2017-06-30 | $36.16M | -6.08% |
| 2017-03-31 | $38.50M | 15.65% |
| 2016-12-31 | $33.29M | -12.00% |
| 2016-09-30 | $37.84M | 4.68% |
| 2016-06-30 | $36.14M | -0.20% |
| 2016-03-31 | $36.22M | 11.87% |
| 2015-12-31 | $32.37M | -13.40% |
| 2015-09-30 | $37.38M | -0.73% |
| 2015-06-30 | $37.66M | -1.75% |
| 2015-03-31 | $38.32M | 17.22% |
| 2014-12-31 | $32.69M | -10.74% |
| 2014-09-30 | $36.63M | 4.57% |
| 2014-06-30 | $35.02M | -3.83% |
| 2014-03-31 | $36.42M | 14.34% |
| 2013-12-31 | $31.85M | -6.44% |
| 2013-09-30 | $34.04M | 4.41% |
| 2013-06-30 | $32.60M | 11.51% |
| 2013-03-31 | $29.24M | 2.60% |
| 2012-12-31 | $28.50M | -6.99% |
| 2012-09-30 | $30.64M | -0.17% |
| 2012-06-30 | $30.69M | 4.96% |
| 2012-03-31 | $29.24M | 14.58% |
| 2011-12-31 | $25.52M | -16.21% |
| 2011-09-30 | $30.46M | -2.19% |
| 2011-06-30 | $31.14M | 1.80% |
| 2011-03-31 | $30.59M | 14.87% |
| 2010-12-31 | $26.63M | -1.94% |
| 2010-09-30 | $27.16M | -2.60% |
| 2010-06-30 | $27.88M | 3.64% |
| 2010-03-31 | $26.90M | 10.24% |
| 2009-12-31 | $24.40M | -3.13% |
| 2009-09-30 | $25.19M | -3.11% |
| 2009-06-30 | $26.00M | 3.81% |
| 2009-03-31 | $25.05M | 6.18% |
| 2008-12-31 | $23.59M | 0.55% |
| 2008-09-30 | $23.46M | -3.22% |
| 2008-06-30 | $24.24M | -1.46% |
| 2008-03-31 | $24.60M | 17.22% |
| 2007-12-31 | $20.99M | - |
Atrion generated $48.77M in revenue during Q2 2024, up 3.04% compared to the previous quarter, and up 121.95% compared to the same period a year ago.
Atrion Revenue Breakdown
Atrion Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 19 | Dec 18 |
|---|---|---|
| Fluid Delivery | $72.12M | $70.61M |
| Cardiovascular | $54.80M | $50.90M |
| Ophthalmology | $7.12M | - |
| Other | $21.03M | $20.46M |
| Opthalmology | - | $10.47M |
Atrion's latest annual revenue breakdown by segment (product or service), as of Dec 19: Fluid Delivery (46.51%), Cardiovascular (35.34%), Other (13.56%), and Ophthalmology (4.59%).
Quarterly Revenue by Product
| Product/Service | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|
| Fluid Delivery | $16.51M | $21.76M | $22.35M | $17.78M | $18.16M | $16.57M | $17.11M | $18.13M | $18.80M |
| Cardiovascular | $11.30M | $10.84M | $14.82M | $10.23M | $15.42M | $11.40M | $13.29M | $13.00M | $13.21M |
| Ophthalmology | $1.17M | $936.00K | $863.00K | $1.47M | $2.28M | $2.77M | $2.85M | $2.79M | - |
| Other | $4.80M | $4.43M | $5.56M | $4.98M | - | - | - | - | - |
| Other Products | - | - | - | - | $5.75M | $6.11M | $4.86M | $4.61M | - |
Atrion's latest quarterly revenue breakdown by segment (product or service), as of Sep 20: Fluid Delivery (48.87%), Cardiovascular (33.44%), Other (14.22%), and Ophthalmology (3.47%).
Atrion Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 19 | Dec 18 |
|---|---|---|---|
| All Other Regions | $43.45M | - | - |
| United State | $109.74M | - | - |
| European Union | $30.31M | - | - |
| Germany | - | $8.00M | $8.90M |
| United States | - | $98.50M | $95.76M |
| Other Countries | - | $48.57M | $47.79M |
Atrion's latest annual revenue breakdown by geography, as of Dec 22: United State (59.80%), All Other Regions (23.68%), and European Union (16.52%).
Quarterly Revenue by Country
| Country | Sep 22 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|
| European Union | $6.37M | - | - | - | - | - | - | - | - | - |
| All other regions | $10.48M | - | - | - | - | - | - | - | - | - |
| United States | $27.78M | $21.86M | - | - | - | - | - | - | - | - |
| Ophthalmology | - | $1.17M | - | - | - | - | - | - | - | - |
| Other | - | $4.80M | - | - | - | - | - | - | - | - |
| Other Countries Less Than 5% Of Revenues | - | $11.38M | $15.52M | $14.16M | - | - | - | - | - | - |
| Cardiovascular | - | $11.30M | - | - | - | - | - | - | - | - |
| Fluid Delivery | - | $16.51M | - | - | - | - | - | - | - | - |
| UNITED STATES | - | - | - | $26.19M | - | - | - | - | - | - |
| GERMANY | - | - | - | $3.24M | - | - | - | - | - | - |
| Other Countries | - | - | - | - | $11.04M | $12.46M | $10.33M | $13.62M | $11.72M | $12.12M |
| Germany | - | - | - | - | $1.57M | $2.16M | $1.68M | $2.29M | $2.67M | - |
| U S | - | - | - | - | - | $26.99M | $23.98M | $24.83M | $24.61M | - |
Atrion's latest quarterly revenue breakdown by geography, as of Sep 22: United States (62.24%), All other regions (23.48%), and European Union (14.27%).
Atrion Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| COO | Cooper Companies | $3.59B | $1.00B |
| ATR | AptarGroup | $3.49B | $910.06M |
| NVST | Envista | $2.57B | $623.60M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| MMSI | Merit Medical Systems | $1.26B | $338.00M |
| ATRC | AtriCure | $399.25M | $116.27M |
| ANGO | AngioDynamics | $303.91M | $75.18M |
| NSTG | NanoString | $127.26M | $48.09M |
| AKYA | Akoya Biosciences | $96.63M | $23.16M |
| KRMD | KORU Medical Systems | $28.52M | $8.20M |
| ATRI | Atrion | - | $48.77M |
ATRI Revenue FAQ
What is Atrion’s yearly revenue?
Atrion's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $183.51M, representing an increase of 11.21% compared to 2021. ATRI's yearly revenue for 2021 was $165.01M, representing an increase of 11.80% compared to 2020.
What is Atrion’s quarterly revenue?
Atrion's quarterly revenue for Q2 2024 was $48.77M, a 3.04% increase from the previous quarter (Q1 2024), and a 11.26% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $47.33M, a 8.60% increase from the previous quarter (Q4 2023), and a 18.36% increase year-over-year (Q1 2023). ATRI's quarterly revenue for Q4 2023 was $43.58M, a 3.99% increase from the previous quarter (Q3 2023), and a 1.70% increase year-over-year (Q4 2022).
What is Atrion’s revenue growth rate?
Atrion's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was -100.00%.
What are Atrion’s revenue streams?
Atrion's revenue streams in c 19 are Fluid Delivery, Cardiovascular, Ophthalmology, and Other. Fluid Delivery generated $72.12M in revenue, accounting 46.51% of the company's total revenue, up 2.14% year-over-year. Cardiovascular generated $54.8M in revenue, accounting 35.34% of the company's total revenue, up 7.65% year-over-year. Ophthalmology generated $7.12M in revenue, accounting 4.59% of the company's total revenue Other generated $21.03M in revenue, accounting 13.56% of the company's total revenue, up 2.74% year-over-year.
What is Atrion’s main source of revenue?
For the fiscal year ending Dec 19, the largest source of revenue of Atrion was Fluid Delivery. This segment made a revenue of $72.12M, representing 46.51% of the company's total revenue.